Paul Beaumont
University of New South Wales
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paul Beaumont.
The Lancet | 1971
Paul Beaumont; P.T. Schofield; Frederick C. Hollows; T.F. Williams; A.W. Steinbeck
Abstract It is suggested that excessive secretion of growth hormone (G.H.) may be the cause of diabetic capillary disease. G.H. hypersecretion inhibits glucose metabolism and results in an accumulation of sorbitol. This in turn causes an osmotic imbalance resulting in damage to tissues.
The Lancet | 1972
Paul Beaumont; Frederick C. Hollows
Abstract A classification of diabetic retinopathy based on clinical observation and investigation is presented. There are four groups: diffuse capillary retinopathy, diabetic lipid retinopathy, diabetic obstructive retinopathy, and minimal diabetic retinopathy. Each group has distinct aetiological features, and the classification can be used to direct therapy.
Diabetes | 1974
Leo Sosula; Paul Beaumont; Frederick C. Hollows; Keith M. Jonson; Hubert L Regtop
The concentration of glycogen β-particles was measured in the inner retinal layers of normal and streptozotocin-diabetic rats with quantitative electron microscopic technics. Diabetes was uncontrolled and of short duration (thirty days). Blood glucose levels in the normal and diabetic animals were 76 ± 8 S.E. and 340 ± 25 S.E. mg./100 ml. Diabetes caused glycogen accumulation in the amacrine, bipolar, ganglionic, Müller and capillary mural cells. Quantitative estimates showed significant increases (p < 0.001) in the glycogen concentrations of cells in the nerve fiber layer (NFL), inner plexiform layer (IPL) and inner nuclear layer (INL) of the diabetic retinas. The glycogen concentrations increased from 6.4 ± 0.41 β-particles per square micron in the normal to 10.5 ± 0.85 in the diabetic Müller endfeet (NFL); from 12.9 ± 1.5 to 38.6 ± 5.0 in the Müller processes (IPL); from 0.81 ± 0.13 to 3.37 ± 0.49 in the neural processes (IPL); from 2.7 ± 0.66 to 17.3 ± 2.4 in the amacrine cell bodies (INL). Diabetic glycogen accumulation occurred at a greater rate in the neurons than in the Müller cells. The amacrine neurons were the most severely affected and contained massive glycogen deposits in their cytoplasm. The glycogen concentration in the neurons was less than that of the Müller cells. However, the Müller cells represent only ∼10 per cent of the total cytoplasm of the IPL, whereas the neurons occupy ∼90 per cent of this layer. From the above data, it is evident that the neurons contain about one third of the total glycogen of the normal IPL. In the diabetic IPL, the total glycogen is approximately evenly distributed between the neural and glial compartments.
Investigative Ophthalmology & Visual Science | 1972
Leo Sosula; Paul Beaumont; Frederick C. Hollows; Keith M. Jonson
Investigative Ophthalmology & Visual Science | 1972
Leo Sosula; Paul Beaumont; Keith M. Jonson; Frederick C. Hollows
Australian and New Zealand Journal of Ophthalmology | 1996
Stuart L. Graham; Ivan Goldberg; Barbara Murray; Paul Beaumont; Beng H. Chong
Australian and New Zealand Journal of Ophthalmology | 1994
Paul Beaumont; H. Kwon Kang
Ophthalmology | 2014
Paul Beaumont; Peter Petocz; Hyong K Kang
Australian and New Zealand Journal of Ophthalmology | 1994
Neil Murray; Peter McCluskey; Denis Wakefield; Paul Beaumont
Clinical and Experimental Ophthalmology | 2005
Paul Beaumont; Hyong K Kang